189 related articles for article (PubMed ID: 33054569)
21. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
22. Screening of acetylcholinesterase inhibitors and characterizing of phytochemical constituents from Dichocarpum auriculatum (Franch.) W.T. Wang & P. K. Hsiao through UPLC-MS combined with an acetylcholinesterase inhibition assay in vitro.
Li P; Liu S; Liu Q; Shen J; Yang R; Jiang B; He C; Xiao P
J Ethnopharmacol; 2019 Dec; 245():112185. PubMed ID: 31446073
[TBL] [Abstract][Full Text] [Related]
23. A combinatorial approach to screen structurally diverse acetylcholinesterase inhibitory plant secondary metabolites targeting Alzheimer's disease.
Choudhir G; Sharma S; Hariprasad P
J Biomol Struct Dyn; 2022; 40(22):11705-11718. PubMed ID: 34351840
[TBL] [Abstract][Full Text] [Related]
24. Cholinesterase Inhibitors from an Endophytic Fungus
Hamed AA; El-Shiekh RA; Mohamed OG; Aboutabl EA; Fathy FI; Fawzy GA; Al-Taweel AM; Elsayed TR; Tripathi A; Al-Karmalawy AA
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985531
[TBL] [Abstract][Full Text] [Related]
25. Molecular interaction studies of acetylcholinesterase with potential acetylcholinesterase inhibitors from the root of Rhodiola crenulata using molecular docking and isothermal titration calorimetry methods.
Li FJ; Liu Y; Yuan Y; Yang B; Liu ZM; Huang LQ
Int J Biol Macromol; 2017 Nov; 104(Pt A):527-532. PubMed ID: 28625836
[TBL] [Abstract][Full Text] [Related]
26. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
Ambure P; Kar S; Roy K
Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
28. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
30. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
Deb PK; Sharma A; Piplani P; Akkinepally RR
Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404
[TBL] [Abstract][Full Text] [Related]
31. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
[TBL] [Abstract][Full Text] [Related]
32. A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.
Kalari M; Abbasi Z; Shasaltaneh MD; Khaleghian A; Moosavi-Nejad Z
J Alzheimers Dis; 2022; 87(4):1503-1516. PubMed ID: 35527546
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of icariin on acetylcholinesterase].
Zhang YD; Cai YN; Zhang Q; Qi ZL; Gao QQ
Yao Xue Xue Bao; 2012 Sep; 47(9):1141-6. PubMed ID: 23227542
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.
Basiri A; Xiao M; McCarthy A; Dutta D; Byrareddy SN; Conda-Sheridan M
Bioorg Med Chem Lett; 2017 Jan; 27(2):228-231. PubMed ID: 27914796
[TBL] [Abstract][Full Text] [Related]
35. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
36. Identification of 1,2,4-Triazolylthioethanone Scaffold for the Design of New Acetylcholinesterase Inhibitors.
Fatiha Muhammad E; Kumar A; Wahab HA; Zhang KYJ
Mol Inform; 2021 Aug; 40(8):e2100020. PubMed ID: 34060234
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
38. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures,
Nisar M; Gondal HY; Cheema ZM; Yousaf S; Nadeem H
J Biomol Struct Dyn; 2023; 41(24):15535-15548. PubMed ID: 37021341
[TBL] [Abstract][Full Text] [Related]
39. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target.
Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716
[TBL] [Abstract][Full Text] [Related]
40. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
